phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

November is American Diabetes Month, and as we do our part to bring awareness to diabetes, we are also celebrating over a century of medical advancements that have transformed diabetes care. From the discovery of insulin in 1921 to today’s long and rapid-acting insulins and the new GLP-1 receptor agonists and SGLT2 inhibitors for type 2 diabetes, innovation has continually improved the health and quality of life for those living with diabetes. These innovations allow for more precise, personalized management and significantly reduce the risk of complications associated with the disease.

American Diabetes Month highlights not only the progress made, but also the ongoing need for more research to improve treatments and, ultimately, find a cure. By recognizing these advancements, we at PhRMA honor both the science and the resilience of millions affected by diabetes and we remain committed to working with policymakers to ensure Americans have affordable access to these advancements.

Learn more here.

Drew Voytal

Drew Voytal, MPA is a Senior Director of public affairs at PhRMA focusing on advocacy and policy communications on key issues, including 340B. His career in health care advocacy, policy and public affairs spans more than a decade in Washington, DC where he has built relationships with key government and industry partners to advance public policy priorities. Drew has personally experienced the benefits of biopharmaceutical research and innovation and is passionate about telling the story of this vital industry.

Drew Voytal

Did the administration consider the importance of blood clot medicines to patients in the price setting process?

September 25, 2024

Did the administration consider the value of innovative diabetes medicines in price setting process?

August 28, 2024

What recent rhetoric on the cost of diabetes and anti-obesity medicines gets wrong

April 9, 2024

New calculator demonstrates how improved adherence to anti-diabetic medicines can benefit people in Medicaid

May 25, 2023

4 key facts on medicine prices and spending

May 9, 2023

Insulin and reconciliation

August 15, 2022

3 factors impacting medication adherence for patients with diabetes

July 20, 2021

New insulin report highlights how incentives benefit middlemen, harm patients

January 22, 2021

Sharing rebates can improve access to medicines and increase health equity

September 30, 2020

Guest post: H.R.3 is the wrong approach to help patients like me

November 26, 2019

Guest post: Sharing discounts and rebates is the right thing to do

October 21, 2019

New report shows more than 160 medicines in development for diabetes and related conditions

April 24, 2019

Five key facts about the market for insulins

April 1, 2019

Six key facts about the market for insulins

December 17, 2018

Ask About Adherence: New study finds one-third of newly diagnosed diabetic patients aren’t starting treatment

August 29, 2018

Reality check: Value-based contracts are good for patients

April 25, 2018

Ask About Adherence: Private-sector collaboration can lead to savings and care improvement

January 25, 2018

New report shows better diabetes management saves money and improves patient outcomes

November 21, 2017

Protect your health: Important disaster preparedness tips for Harvey and Irma

September 6, 2017

mother and son happily hugging

Diabetes

Celebrating advances in diabetes research

November 21, 2024

mother and son happily hugging

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list